MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Excessive daytime sleepiness(EDS)"

  • 2018 International Congress

    Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson’s disease?

    A. Sarwar, S. Moore (Houston, TX, USA)

    Objective: To determine if REM sleep behavior disorder (RBD) is associated with excessive daytime sleepiness (ES) in military veterans with Parkinson’s disease (PD). Background: Nearly…
  • 2018 International Congress

    Safinamide and Rasagiline effect on motor fluctuation, sleep quality and daytime sleepiness in Parkinson’s Disease: A validated questionnaires study

    C. Liguori, A. Stefani, N. Mercuri, M. Pierantozzi (Rome, Italy)

    Objective: This is an observational study aimed at evaluating the effect of Safinamide and Rasagiline on motor fluctuations, subjective sleep and daytime sleepiness in Parkinson’s…
  • 2018 International Congress

    Clinical heterogeneity of excessive daytime sleepiness in Parkinson’s disease

    O. Levin, O. Iakovleva, M. Poluektov (Moscow, Russian Federation)

    Objective: To examine reasons and associated clinical features of excessive daytime sleepiness (EDS) in patients with Parkinson’s disease (PD). Background: Patients with EDS can divided…
  • 2018 International Congress

    Progression of sleep disorders spectrum in Parkinson’s Disease: A 5 year clinical longitudinal study

    Objective: To investigate longitudinal changes in the prevalence of different sleep disorders in the PPMI cohort of patients with Parkinson’s Disease (PD). Background: Sleep disturbances…
  • 2018 International Congress

    Prodromal features of Parkinson’s disease in women

    K. Hughes, X. Gao, J. Baker, C. Stephen, I. Kim, L. Valeri, M. Schwarzschild, A. Ascherio (Boston, MA, USA)

    Objective: To identify how prodromal features interact to determine Parkinson’s disease (PD) risk in women. Background: The neuronal loss that leads to PD progresses insidiously…
  • 2018 International Congress

    The prevalence and associated features of REM sleep without atonia

    F. Dijkstra, M. Viaene, I. de Volder, D. Crosiers, P. Cras (Antwerp, Belgium)

    Objective: 1. To determine the prevalence of idiopathic and secondary REM sleep without atonia (RSWA). 2. To assess excessive daytime sleepiness and depressive symptoms in…
  • 2017 International Congress

    Relationship between sleep profiles and clinical features in Parkinson’s disease

    Y.-Y. Lin, R.-S. Chen, C.-S. Lu, Y.-Z. Huang, Y.-H. Weng, T.-H. Yeh, W.-Y. Lin, J. Hung (Taoyuan, Taiwan)

    Objective: To document the prevalence of sleep disturbance and excessive daytime sleepiness (EDS) in Taiwanese Parkinson’s disease (PD) patients and to identify the risk factors…
  • 2017 International Congress

    Excessive daytime sleepiness in Parkinson’s disease: risk factors and clinical associations

    O. Babkina, O. Levin, M. Poluektov (Moscow, Russian Federation)

    Objective: To examine the frequency and risk factors of excessive daytime sleepiness (EDS) in patients with PD and to determine relationships between EDS and another…
  • 2017 International Congress

    Somnolence as untoward stimulation effect in subthalamic deep brain stimulation (STN DBS) for Parkinson’s disease (PD)

    F. Danisi, C. Miller (Poughkeepsie, NY, USA)

    Objective: Excessive daytime sleepiness is a relatively common feature in PD. However, it has not been reported as a side effect of STN DBS. We…
  • 2017 International Congress

    Istradefylline improves not only motor symptoms but also sleep disturbance, daytime sleepiness, and QOL of Parkinson’s disease patients.

    K. Ohta, Y. Kujuro, T. Osada (Tokyo, Japan)

    Objective:  This study analyzed the clinical effectiveness of istradefylline in terms of sleep disturbance in Parkinson’s disease (PD) patients. Background: A selective adenosine A2A receptor…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley